BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7109637)

  • 1. A critical review of immunotherapy of disseminated renal adenocarcinoma.
    Montie JE; Bukowski RM; James RE; Straffon RA; Stewart BH
    J Surg Oncol; 1982 Sep; 21(1):5-8. PubMed ID: 7109637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phase II evaluation of Bacillus Calmette-Guerin plus megestrol acetate in patients with metastatic renal adenocarcinoma.
    Laucius JF; Patel YA; Lusch CJ; Koons LS; Bellet RE; Mastrangelo MJ
    Med Pediatr Oncol; 1977; 3(3):237-42. PubMed ID: 618010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guerin in the treatment of adenocarcinoma of the kidney.
    Morales A; Eidinger D
    J Urol; 1976 Apr; 115(4):377-80. PubMed ID: 1263310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
    Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
    Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of disseminated renal cell carcinoma with transfer factor.
    Montie JE; Bukowski RM; Deodhar SH; Hewlett JS; Stewart BH; Straffon RA
    J Urol; 1977 May; 117(5):553-6. PubMed ID: 859196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
    Spitler LE; Levin AS; Wybran J
    Cell Immunol; 1976 Jan; 21(1):1-19. PubMed ID: 764975
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of renal cell carcinoma.
    deKernion JB
    Prog Clin Biol Res; 1984; 153():409-21. PubMed ID: 6206509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced renal cell carcinoma.
    deKernion JB; Lindner A
    Prog Clin Biol Res; 1982; 100():641-59. PubMed ID: 6183675
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG immunotherapy of metastatic adenocarcinoma of the kidney.
    Eidinger D; Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):339-41. PubMed ID: 748790
    [No Abstract]   [Full Text] [Related]  

  • 11. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 12. Megestrol acetate.
    Canetta R; Florentine S; Hunter H; Lenaz L
    Cancer Treat Rev; 1983 Sep; 10(3):141-57. PubMed ID: 6352021
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and systemic bacillus Calmette-Guerin therapy in metastatic renal cancer: a phase II trial.
    Morales A; Wilson JL; Pater JL; Loeb M
    J Urol; 1982 Feb; 127(2):230-5. PubMed ID: 7038142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
    Cedermark BJ; Gunven P; Hammarberg C
    J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma.
    Costanza M; Buechler M; Munzenreider J; Emami B; Mukherji B; Shucart W; Scott M; Nathanson L; Rudders R; Stein B; Post K; Piro A
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1589-92. PubMed ID: 231595
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology Association.
    Richards F; Howard V; Shore A; Muss HB; White DR; Jackson DV; Cooper MR; Bearden J; Stuart JJ; Sartiano G; Rhyne AL; Spurr CL
    Cancer; 1981 Jun; 47(12):2827-32. PubMed ID: 6266642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental percutaneous renal embolization using BCG-saturated gelfoam.
    Wright KC; Soo CS; Wallace S; McDonald MW; Ayala A
    Cardiovasc Intervent Radiol; 1982; 5(5):260-3. PubMed ID: 7159889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus calmette-guerin (BCG) adjuvant therapy in stage D prostate cancer.
    Guinan P; Toronchi E; Shaw M; Crispin R; Sharifi R
    Urology; 1982 Oct; 20(4):401-3. PubMed ID: 6755855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.